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Summary
Background:  Brucella  melitensis  and  B.  abortus  are  the  species  generally  isolated
from  human  samples  in  Turkey.  Several  studies  have  also  demonstrated  the  presence
of  antibodies  against  B.  canis.
Case  report  and  study:  Brucella  spp.  was  isolated  from  blood  culture  from  a  35-
year-old  male  with  clinical  signs  and  symptoms  of  acute  meningitis,  including  fever
lasting  for  1  week.  Multiplex  PCR  demonstrated  B.  suis, and  biochemical  features
indicated  biovar  1.
Conclusions:  This  report  is  the  ﬁrst  emphasizing  that  B.  suis  should  be  considered
among  the  causes  of  brucellosis  in  Turkey.
©  2016  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
Limited.  All  rights  reserved.∗ Corresponding author at: Department of Infectious Diseases
nd Clinical Microbiology, Pamukkale University, Faculty of
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rucellosis  remains  an  endemic  zoonosis  in  Mid-
le Eastern  and  Mediterranean  countries,  including
urkey.  Brucella  melitensis, B.  abortus  and  B.  suis
re responsible  for  a  substantial  proportion  of
nfections  in  humans.  Although  observed  less  fre-
uently, B.  canis  and  Brucella  species  from  aquatic
ammals  can  cause  brucellosis  in  humans  [1].
nces. Published by Elsevier Limited. All rights reserved.
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The  relative  abundance  of  Brucella  species  vary
among  geographic  regions.  B.  melitensis  is  the
most common  species  isolated  in  the  Middle  East,
whereas  B.  abortus  and  B.  suis  are  more  frequently
isolated in  regions  of  South  America,  the  USA  and
many European  countries  [1]. In  Balkan  countries,
such as  Greece,  B.  melitensis  is  a  more  common
cause of  infection  in  humans  than  is  other  Bru-
cella species  [2].  Similarly,  in  Turkey,  B.  melitensis
accounts for  the  majority  of  isolated  species,  while
B. abortus  is  isolated  less  frequently  [3,4]. More-
over, the  presence  of  antibodies  against  B.  canis
was demonstrated  in  humans  previously  [5].
However, there  have  been  no  reports  from
Turkey demonstrating  B.  suis  infection  in  animals
or humans.  In  this  study,  we  report  the  ﬁrst  case  of
acute Brucella  meningitis  from  Turkey  in  which  the
infectious  agent  was  B.  suis.
Case report and study
Case
A  35-year-old  man  was  admitted  to  the  hospital
with a  7-day  history  of  fever,  chills  and  shivering,
fatigue, low  back  pain,  and  headache.  He  was  a
sheep and  cattle  breeder  and  reported  hunting
wild boars  several  times  in  the  last  6  months  and
feeding  the  boar  meat  to  his  dogs.  Upon  physical
examination, his  fever  was  39.2 ◦C,  and  he  exhib-
ited confusion.  He  had  neck  stiffness  and  positive
Kernig’s sign.  Laboratory  results  were  hemoglobin
15.5 g/dl,  hematocrit  46.8%,  white  blood  cell
count 7290/mm3, platelet  count  257,000/mm3, and
C-reactive  protein  (CRP)  10.1  mg/dl;  other  bio-
chemical  tests  were  within  the  normal  ranges.
The contrast-enhanced  cranial  and  lumbar  mag-
netic resonance  imaging  results  were  normal.  CSF
leukocyte  count  was  10/mm3, and  the  CSF  glucose
level was  69  mg/dl  (simultaneous  serum  glucose
was 121  mg/dl)  and  protein  level  was  59  mg/dl.
He was  started  on  empirical  antibiotic  treatment
with ceftriaxone  2×  2 g,  doxycycline  2×  100  mg
and rifampicin  1×  900  mg  for  Brucella  meningitis
because of  his  occupation  and  hunting  activities,
as well  as  clinical  presentation  associated  with
Rose Bengal  positivity.  Serum  Brucella  tube  agglu-
tination  test  (SAT)  was  positive  at  1/80  titer,  and
SAT with  Coombs  antiserum  was  positive  at  1/160
titer, whereas  a  CSF  Brucella  tube  agglutination
test was  negative.  On  the  third  day  of  blood  cul-
ture, growth  was  detected.  Gram  staining  revealed
Gram-negative  coccobacilli.  Samples  from  blood
culture  were  plated  on  blood  agar,  eosin-methylene
blue (EMB)  agar  and  chocolate  agar.  Inoculated
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lates  were  incubated  at  37 ◦C  in  normal  atmo-
pheric conditions  and  with  the  addition  of  10%  CO2
or  4—5  days.  At  the  end  of  the  incubation,  small,
onvex, non-hemolytic  colonies  were  observed  in
he blood  and  chocolate  agars.  EMB  agar  was  nega-
ive for  growth.
dentiﬁcation and biotyping
he  culture  was  identiﬁed  in  a three-stage  pro-
edure [6]. In stage  1,  the  isolate  was  checked
or colony  morphology  by  stereomicroscope  and  for
gglutination  with  neutral  acriﬂavin  (0.1%,  w/v)
Sigma A8126).  In  stage  2,  for  species  determi-
ation, the  following  tests  were  performed  on
ll isolates:  serum  requirement  for  growth,  oxi-
ase and  urease  production  and  lysis  with  Tbilisi
hage at  routine  test  dilution  (RTD)  and  104 × RTD
nd R/C  phage  at  RTD.  In  stage  3,  for  bio-
yping, the  production  of  H2S,  CO2 requirement
or growth,  growth  in  media  containing  thionine
T3387, Sigma)  (20  g/ml),  basic  fuchsine  (115937,
erck)  (20  g/ml),  and  safranin  O  (S2255,  Sigma)
100 g/ml)  dyes,  agglutination  with  A  and  M
onospeciﬁc  antisera,  and  R  antiserum  were  inves-
igated.
olecular typing
olecular  typing  of  Brucella  species  by  multi-
lex PCR  (Bruce-ladder)  was  undertaken  using  the
ethod described  by  Mayer  Scholl  et  al.  [7].  For
xtraction  of bacterial  genomic  DNA,  a loopful  of
acterial culture  was  taken  from  the  petri  plate
nd re-suspended  in  200  l  sterile  distilled  water,
hich was  mixed  and  incubated  at  99 ◦C  for  10  min
nd ﬁnally  centrifuged  at 12,000  ×  g for  20  s.  The
esulting  supernatants  were  used  as  the  DNA  tem-
late for  Bruce-ladder.  The  assay  was  carried  out
n a 25  l  reaction  mixture  containing  2×  Qiagen
ultiplex Master  Mix  (Qiagen,  Germany),  0.2  M  of
ach primer  in  cocktail  of  nine  primer  sets  and
 l template  DNA.  Ampliﬁcations  were  initiated  by
enaturing  the  sample  for  15  min  at  95 ◦C  followed
y template  denaturation  at  94 ◦C  for  30  s, primer
nnealing at  58 ◦C  for  90  s,  and  primer  extension
t 72 ◦C  for  180  s for  a  total  of  30  cycles.  After
he last  cycle,  samples  were  incubated  for  an  addi-
ional 10  min  at  72 ◦C.  Ampliﬁcation  products  were
eparated  on  1.5%  agarose  gels.esults
he  isolated  strain  showed  a proﬁle  matching  B.  suis
Fig.  1),  and  the  isolate  was  identiﬁed  as  B.  suis
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Figure  1  Lane  1:  Isolated  strain,  lane  2:  B.  melitensis
16  M,  lane  3:  B.  suis  1330,  lane  4—7:  test  isolates,  lane
8:  negative  control,  lane  9:  ladder.  Lane  1  shows  B.  suis
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−roﬁle,  while  the  rest  of  the  test  strains  were  negative
or  any  known  Brucella  species.
iovar  1  based  on  conventional  biotyping  proce-
ures (Table  1).
iscussion
his  report  is  the  ﬁrst  to  describe  a  patient  with
rucella infection  due  to  B.  suis  in  Turkey.  Detec-
ion of  Brucella  species  is of  critical  importance  in
valuating  pathogen  prevalence  and  disease  risk.
n countries  where  domestic  animal  brucellosis  has
een eradicated,  wild  animals  may  be  sources  of
. melitensis, B.  abortus  or  B.  suis  infection  in
umans and  domestic  animals  [8,9]. Transmission
f B.  suis  to  domestic  animals  from  wild  boars  and
ild rabbits  has  been  reported  in  the  USA  and  sev-
ral European  countries  [9—11]. Although  B.  suis  is
mong the  causes  of  brucellosis  in  pigs  and  humans
n Southeast  Asia  and  India,  there  are  no  data  on  B.
uis infection  in  animals  or  humans  in  Turkey  or  in
eighboring  Middle  Eastern  countries  [1,3,12,13].
tudies of  the  control  of  animal  brucellosis  in  Turkey
ave been  conducted  for  many  years,  and  a  new
eriod began  in  2009  with  the  involvement  of  the
uropean  Union  [13]. Despite  claims  of  an  increase
n the  number  of  wild  boars,  there  are  no  cur-
ent data  on  many  species  of  wild  boars  in  Turkey.
herefore, data  regarding  the  number  of  wild  boars
nd the  prevalence  of  Brucella  infections  in  the
oar population  may  be  beneﬁcial  when  considering
ossible transmission  between  wild  and  domestic
nimals.
Accurate diagnosis  of  brucellosis  is  generally  suf-
cient to  decide  the  treatment,  and  subtyping  of
rucella  species  is  not  necessary  in  daily  practice
14].  However,  there  are  many  misdiagnosed  cases T
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of  brucellosis.  Carrington  et  al.  reported  a  bru-
cellosis  case  due  to  B.  suis  in  a  pig  hunter,  which
resulted  in  death  because  of  mistreatment  due
to misdiagnosis  of  infection  with  Ochrobactrum
anthropi by  automated  diagnosis  methods  [15].
Conclusions
B.  suis  is  one  of  the  species  responsible  for  bru-
cellosis in  Turkey  and  should  be  considered  to
be a  candidate  infectious  agent,  particularly  in
patients  who  report  outdoor  activities,  such  as  wild
boar hunting.  In  addition,  B.  suis  infection  may
be endemic  but  undiagnosed  in  wild  animals  in
Turkey;  therefore,  further  epidemiological  studies
are required  to  evaluate  the  need  for  preventive
actions in  public  health.
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